Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Infect Dis. Nov 22, 2023; 13(4): 37-48
Published online Nov 22, 2023. doi: 10.5495/wjcid.v13.i4.37
Table 2 Univariate and multivariate analysis of the development of severe infection in elderly patients with coronavirus disease 2019
Variables
Univariate analysis OR (95%CI)
P value
Multivariate analysis OR (95%CI)
P value
Age1.084 (0.978, 1.202)0.126--
Sex0.575 (0.1, 3.322)0.536--
Vaccinations0.636 (0.039, 10.385)0.751--
Chronic respiratory disease0.559 (0.025, 12.453)0.713--
Diabetes mellitus7.76 (0.446, 134.92)0.16--
Hypertension3.267 (0.365, 29.275)0.29--
Coronary heart disease0.142 (0.01, 1.926)0.142--
Cerebral infarction7.757 (0.704, 85.443)0.0944.26 (1.012, 17.937)0.048
Chronic kidney disease0.057 (0.001, 4.578)0.2--
Neurodegenerative diseases19.385 (0.149, 2527.003)0.233--
Neoplastic disease0.527 (0.022, 12.846)0.695--
Immune system disease0 (0, 203.169)0.213--
WBC1.096 (0.669, 1.794)0.716--
Neutrophil percentage1.125 (0.95, 1.331)0.172--
eGFR1.044 (0.966, 1.128)0.281--
NLR1.017 (0.636, 1.626)0.943--
SIRI1.003 (0.534, 1.883)0.993--
CRP1.023 (0.984, 1.063)0.251--
PCT1.552 (0.67, 3.598)0.305--
Oxygen saturation0.513 (0.369, 0.714)0.0000.573 (0.451, 0.728)0.000
Lactic acid0.768 (0.269, 2.194)0.622--
D-dimers1.156 (0.754, 1.772)0.5071.394 (1, 1.944)0.05
Viral shedding time1.066 (0.892, 1.274)0.484--
Lianhua Qingwen Granule0.486 (0.055, 4.302)0.517--
Paxlovid2.505 (0.19, 33.049)0.485--